These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 20603272)

  • 41. ACE-inhibitor, AT1-receptor-antagonist, or both? A clinical pharmacologist's perspective after publication of the results of ONTARGET.
    Schindler C
    Ther Adv Cardiovasc Dis; 2008 Aug; 2(4):233-48. PubMed ID: 19124424
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Involvement of uric acid transporters in alteration of serum uric acid level by angiotensin II receptor blockers.
    Sato M; Iwanaga T; Mamada H; Ogihara T; Yabuuchi H; Maeda T; Tamai I
    Pharm Res; 2008 Mar; 25(3):639-46. PubMed ID: 17674156
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative vascular and renal tubular effects of angiotensin II receptor blockers combined with a thiazide diuretic in humans.
    Coltamai L; Maillard M; Simon A; Vogt B; Burnier M
    J Hypertens; 2010 Mar; 28(3):520-6. PubMed ID: 20104189
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Telmisartan has the strongest binding affinity to angiotensin II type 1 receptor: comparison with other angiotensin II type 1 receptor blockers.
    Kakuta H; Sudoh K; Sasamata M; Yamagishi S
    Int J Clin Pharmacol Res; 2005; 25(1):41-6. PubMed ID: 15864875
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Homology modeling, binding site identification and docking study of human angiotensin II type I (Ang II-AT1) receptor.
    Vyas VK; Ghate M; Patel K; Qureshi G; Shah S
    Biomed Pharmacother; 2015 Aug; 74():42-8. PubMed ID: 26349961
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The coronary endothelium behaves as a functional diffusion barrier for intravascular Angiotensin II.
    Rubio R; Torres-Tirado D; Castillo-Hernandez J; Chi-Ahumada E; Ramiro-Diaz J; Knabb M
    Vascul Pharmacol; 2013 Jan; 58(1-2):54-63. PubMed ID: 22925777
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical experience with the use of angiotensin receptor blockers in patients with cardiovascular, cerebrovascular and renal diseases.
    Chrysant SG
    Curr Clin Pharmacol; 2006 May; 1(2):139-46. PubMed ID: 18666366
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevention of salt-induced hypertension and fibrosis by AT1-receptor blockers in Dahl S rats.
    Liang B; Leenen FH
    J Cardiovasc Pharmacol; 2008 May; 51(5):457-66. PubMed ID: 18418273
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Leveraging NMR and X-ray Data of the Free Ligands to Build Better Drugs Targeting Angiotensin II Type 1 G-Protein Coupled Receptor.
    Kellici TF; Ntountaniotis D; Kritsi E; Zervou M; Zoumpoulakis P; Potamitis C; Durdagi S; Salmas RE; Ergun G; Gokdemir E; Halabalaki M; Gerothanassis IP; Liapakis G; Tzakos A; Mavromoustakos T
    Curr Med Chem; 2016; 23(1):36-59. PubMed ID: 26572611
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Insights into the activation and inhibition of angiotensin II type 1 receptor in the mechanically loaded heart.
    Wu J; You J; Wang S; Zhang L; Gong H; Zou Y
    Circ J; 2014; 78(6):1283-9. PubMed ID: 24813328
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Elevated angiotensin II induces platelet apoptosis through promoting oxidative stress in an AT1R-dependent manner during sepsis.
    Xu DF; Liu YJ; Mao YF; Wang Y; Xu CF; Zhu XY; Jiang L
    J Cell Mol Med; 2021 Apr; 25(8):4124-4135. PubMed ID: 33624364
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Mechanisms underlying angiotensin II-independent activation of angiotensin II type 1 receptor].
    Akazawa H; Komuro I
    Nihon Rinsho; 2012 Sep; 70(9):1492-8. PubMed ID: 23012793
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunosuppressive effect of angiotensin receptor blocker on stimulation of mice CTLs by angiotensin II.
    Maeda A; Okazaki T; Inoue M; Kitazono T; Yamasaki M; Lemonnier FA; Ozaki S
    Int Immunopharmacol; 2009 Sep; 9(10):1183-8. PubMed ID: 19540938
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Angiotensin II receptor blockers for the treatment of hypertension.
    See S
    Expert Opin Pharmacother; 2001 Nov; 2(11):1795-804. PubMed ID: 11825317
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Angiotensin Type 1 Receptor Blockers in Heart Failure.
    Singh KD; Karnik SS
    Curr Drug Targets; 2020; 21(2):125-131. PubMed ID: 31433752
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Angiotensin II signaling through the AT1a and AT1b receptors does not have a role in the development of cerulein-induced chronic pancreatitis in the mouse.
    Ulmasov B; Xu Z; Talkad V; Oshima K; Neuschwander-Tetri BA
    Am J Physiol Gastrointest Liver Physiol; 2010 Jul; 299(1):G70-80. PubMed ID: 20413721
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of the renin-angiotensin system in gynecologic cancers.
    Ino K; Shibata K; Yamamoto E; Kajiyama H; Nawa A; Mabuchi Y; Yagi S; Minami S; Tanizaki Y; Kobayashi A; Kikkawa F
    Curr Cancer Drug Targets; 2011 May; 11(4):405-11. PubMed ID: 21395551
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transdermal Delivery of AT1 Receptor Antagonists Reduce Blood Pressure and Reveal a Vasodilatory Effect on Kidney Blood Vessels.
    Michalatou M; Androutsou ME; Antonopoulos M; Vlahakos DV; Agelis G; Zulli A; Qaradakhi T; Mikkelsen K; Apostolopoulos V; Matsoukas J
    Curr Mol Pharmacol; 2018; 11(3):226-236. PubMed ID: 29676239
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neuroprotective effects of AT1 receptor antagonists after experimental ischemic stroke: what is important?
    Culman J; Jacob T; Schuster SO; Brolund-Spaether K; Brolund L; Cascorbi I; Zhao Y; Gohlke P
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Sep; 390(9):949-959. PubMed ID: 28669009
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of angiotensin II type 1 receptor blocker on 12-lipoxygenase activity and slit diaphragm protein expression in type 2 diabetic rat glomeruli.
    Xu HZ; Wang WN; Zhang YY; Cheng YL; Xu ZG
    J Nephrol; 2016 Dec; 29(6):775-782. PubMed ID: 27021232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.